<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01981057</url>
  </required_header>
  <id_info>
    <org_study_id>MUV-Numeta</org_study_id>
    <nct_id>NCT01981057</nct_id>
  </id_info>
  <brief_title>Clinical Experience With Numeta in Preterm Infants</brief_title>
  <acronym>Numeta</acronym>
  <official_title>Clinical Experience With Numeta- Impact on Intake of Nutrients and Costs</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Medical University of Vienna</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Medical University of Vienna</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The aim of this prospective noninterventional study is to evaluate the clinical application
      of Numeta® in preterm infants and critically ill neonates in comparison to individualized
      prescribed parenteral nutrition. With the prescription software Cato-PAN® (by Cato software
      solutions) exact valid prescriptions for ordering parenteral nutrition solutions for
      premature infants are compared. Each PN solution is prescribed individually as well as with
      Numeta. Prescriptions were mirrored with respect to weight, venous approach, total volume and
      amount of enteral feeding, 24h medication and flipped vice versa. The key nutrient for
      calculating Numeta prescriptions was protein. The results of PN prescriptions were compared
      with each other/ESPGHAN recommendations. The investigators hypothesize that nutrimental
      content of Numeta prescriptions is equal to individually prescribed .parenteral nutrition
      solutions
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>February 2013</start_date>
  <completion_date type="Actual">November 2013</completion_date>
  <primary_completion_date type="Actual">November 2013</primary_completion_date>
  <study_type>Observational [Patient Registry]</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Crossover</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <target_duration>6 Days</target_duration>
  <primary_outcome>
    <measure>Protein</measure>
    <time_frame>6 weeks</time_frame>
    <description>Prescriptions for protein in parenteral nutrition solutions will be ordered individually and flipped with Numeta or &quot;vice versa&quot;. This mirroring will be performed with the Cato-Pan prescription software. Subsequently the following nutrients will be calculated and compared with each other and with the ESPGHAN recommendations.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Energy</measure>
    <time_frame>6 weeks</time_frame>
    <description>Prescriptions for energy in parenteral nutrition solutions will be ordered individually and flipped with Numeta or &quot;vice versa&quot;. This mirroring will be performed with the Cato-Pan prescription software. Subsequently the following nutrients will be calculated and compared with each other and with the ESPGHAN recommendations</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Carbohydrates</measure>
    <time_frame>6 weeks</time_frame>
    <description>Prescriptions for carbohydrates in parenteral nutrition solutions will be ordered individually and flipped with Numeta or &quot;vice versa&quot;. This mirroring will be performed with the Cato-Pan prescription software. Subsequently the following nutrients will be calculated and compared with each other and with the ESPGHAN recommendations</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Fat</measure>
    <time_frame>6 weeks</time_frame>
    <description>Prescriptions for fat in parenteral nutrition solutions will be ordered individually and flipped with Numeta or &quot;vice versa&quot;. This mirroring will be performed with the Cato-Pan prescription software. Subsequently the following nutrients will be calculated and compared with each other and with the ESPGHAN recommendations</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Sodium</measure>
    <time_frame>6 weeks</time_frame>
    <description>Prescriptions for sodium in parenteral nutrition solutions will be ordered individually and flipped with Numeta or &quot;vice versa&quot;. This mirroring will be performed with the Cato-Pan prescription software. Subsequently the following nutrients will be calculated and compared with each other and with the ESPGHAN recommendations</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Potassium</measure>
    <time_frame>6 weeks</time_frame>
    <description>Prescriptions for Potassium in parenteral nutrition solutions will be ordered individually and flipped with Numeta or &quot;vice versa&quot;. This mirroring will be performed with the Cato-Pan prescription software. Subsequently the following nutrients will be calculated and compared with each other and with the ESPGHAN recommendations</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Calcium</measure>
    <time_frame>6 weeks</time_frame>
    <description>Prescriptions for calcium in parenteral nutrition solutions will be ordered individually and flipped with Numeta or &quot;vice versa&quot;. This mirroring will be performed with the Cato-Pan prescription software. Subsequently the following nutrients will be calculated and compared with each other and with the ESPGHAN recommendations</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Magnesium</measure>
    <time_frame>6 weeks</time_frame>
    <description>Prescriptions for magnesium in parenteral nutrition solutions will be ordered individually and flipped with Numeta or &quot;vice versa&quot;. This mirroring will be performed with the Cato-Pan prescription software. Subsequently the following nutrients will be calculated and compared with each other and with the ESPGHAN recommendations</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Phosphorous</measure>
    <time_frame>6 weeks</time_frame>
    <description>Prescriptions for phosphorous in parenteral nutrition solutions will be ordered individually and flipped with Numeta or &quot;vice versa&quot;. This mirroring will be performed with the Cato-Pan prescription software. Subsequently the following nutrients will be calculated and compared with each other and with the ESPGHAN recommendations</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Osmolarity</measure>
    <time_frame>6 weeks</time_frame>
    <description>Osmolarity in parenteral nutrition solutions will be calculated individually and flipped with Numeta or &quot;vice versa&quot;. This mirroring will be performed with the Cato-Pan prescription software. Subsequently the following nutrients will be calculated and compared with each other and with the ESPGHAN recommendations</description>
  </secondary_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Actual">50</enrollment>
  <condition>Premature Infants</condition>
  <arm_group>
    <arm_group_label>Numeta</arm_group_label>
    <description>parenteral receipt prescribed with Numeta</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Individual</arm_group_label>
    <description>individually prescribed parenteral receipt</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Numeta</intervention_name>
    <description>parenteral receipt prescribed with Numeta</description>
    <arm_group_label>Numeta</arm_group_label>
    <arm_group_label>Individual</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Individual</intervention_name>
    <description>parenteral receipt prescribed individually</description>
    <arm_group_label>Numeta</arm_group_label>
    <arm_group_label>Individual</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        preterm infants
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  preterm infants &lt;37 weeks gestational age

          -  parenteral nutrition therapy

        Exclusion Criteria:

          -  hypersensitivity to egg, soy or peanut proteins or to any of the active substances

          -  congenital abnormality of the amino acid metabolism

          -  pathogenically elevated plasma concentrations of sodium, potassium, magnesium, calcium
             and/or phosphorous

          -  severe hyperglycemia

          -  severe hyperlipidemia

          -  severe disorders of lipid metabolism characterized by hypertriglyceridemia
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>3 Months</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Nadja Haiden, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Medical University of Vienna</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Medical University of Vienna</name>
      <address>
        <city>Vienna</city>
        <zip>1090</zip>
        <country>Austria</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Austria</country>
  </location_countries>
  <verification_date>May 2014</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>November 5, 2013</study_first_submitted>
  <study_first_submitted_qc>November 5, 2013</study_first_submitted_qc>
  <study_first_posted type="Estimate">November 11, 2013</study_first_posted>
  <results_first_submitted>May 10, 2014</results_first_submitted>
  <results_first_submitted_qc>May 10, 2014</results_first_submitted_qc>
  <results_first_posted type="Estimate">June 9, 2014</results_first_posted>
  <last_update_submitted>September 25, 2017</last_update_submitted>
  <last_update_submitted_qc>September 25, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">October 26, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Medical University of Vienna</investigator_affiliation>
    <investigator_full_name>Nadja Haiden,MD</investigator_full_name>
    <investigator_title>Assoc.Prof.MD</investigator_title>
  </responsible_party>
  <keyword>parenteral nutrition</keyword>
  <keyword>Numeta</keyword>
  <keyword>prescription software Cato Pan</keyword>

  <clinical_results>

    <participant_flow>
      <group_list>
        <group group_id="P1">
          <title>Numeta</title>
          <description>parenteral receipt prescribed with Numeta
Numeta: parenteral receipt prescribed with Numeta
Individual: parenteral receipt prescribed individually</description>
        </group>
        <group group_id="P2">
          <title>Individual</title>
          <description>individually prescribed parenteral receipt
Numeta: parenteral receipt prescribed with Numeta
Individual: parenteral receipt prescribed individually</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="50"/>
                <participants group_id="P2" count="50"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="50"/>
                <participants group_id="P2" count="50"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="0"/>
              </participants_list>
            </milestone>
          </milestone_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <group_list>
        <group group_id="B1">
          <title>Numeta</title>
          <description>parenteral receipt prescribed with Numeta
Numeta: parenteral receipt prescribed with Numeta
Individual: parenteral receipt prescribed individually</description>
        </group>
        <group group_id="B2">
          <title>Individual</title>
          <description>individually prescribed parenteral receipt
Numeta: parenteral receipt prescribed with Numeta
Individual: parenteral receipt prescribed individually</description>
        </group>
        <group group_id="B3">
          <title>Total</title>
          <description>Total of all reporting groups</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="50"/>
            <count group_id="B2" value="50"/>
            <count group_id="B3" value="100"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>days of gestation</units>
          <param>Median</param>
          <dispersion>Full Range</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="233" lower_limit="189" upper_limit="283"/>
                    <measurement group_id="B2" value="233" lower_limit="189" upper_limit="283"/>
                    <measurement group_id="B3" value="233" lower_limit="189" upper_limit="283"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Age</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>&lt;=18 years</title>
                  <measurement_list>
                    <measurement group_id="B1" value="50"/>
                    <measurement group_id="B2" value="50"/>
                    <measurement group_id="B3" value="100"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Between 18 and 65 years</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>&gt;=65 years</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Sex: Female, Male</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>Female</title>
                  <measurement_list>
                    <measurement group_id="B1" value="21"/>
                    <measurement group_id="B2" value="21"/>
                    <measurement group_id="B3" value="42"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Male</title>
                  <measurement_list>
                    <measurement group_id="B1" value="29"/>
                    <measurement group_id="B2" value="29"/>
                    <measurement group_id="B3" value="58"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Region of Enrollment</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>Austria</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="50"/>
                    <measurement group_id="B2" value="50"/>
                    <measurement group_id="B3" value="100"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Protein</title>
        <description>Prescriptions for protein in parenteral nutrition solutions will be ordered individually and flipped with Numeta or &quot;vice versa&quot;. This mirroring will be performed with the Cato-Pan prescription software. Subsequently the following nutrients will be calculated and compared with each other and with the ESPGHAN recommendations.</description>
        <time_frame>6 weeks</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Numeta</title>
            <description>parenteral receipt prescribed with Numeta
Numeta: parenteral receipt prescribed with Numeta
Individual: parenteral receipt prescribed individually</description>
          </group>
          <group group_id="O2">
            <title>Individual</title>
            <description>individually prescribed parenteral receipt
Numeta: parenteral receipt prescribed with Numeta
Individual: parenteral receipt prescribed individually</description>
          </group>
        </group_list>
        <measure>
          <title>Protein</title>
          <description>Prescriptions for protein in parenteral nutrition solutions will be ordered individually and flipped with Numeta or &quot;vice versa&quot;. This mirroring will be performed with the Cato-Pan prescription software. Subsequently the following nutrients will be calculated and compared with each other and with the ESPGHAN recommendations.</description>
          <units>g/kg/d</units>
          <param>Median</param>
          <dispersion>Full Range</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="50"/>
                <count group_id="O2" value="50"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="3.1" lower_limit="1.6" upper_limit="4.1"/>
                    <measurement group_id="O2" value="3.6" lower_limit="1.7" upper_limit="5"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Energy</title>
        <description>Prescriptions for energy in parenteral nutrition solutions will be ordered individually and flipped with Numeta or &quot;vice versa&quot;. This mirroring will be performed with the Cato-Pan prescription software. Subsequently the following nutrients will be calculated and compared with each other and with the ESPGHAN recommendations</description>
        <time_frame>6 weeks</time_frame>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Carbohydrates</title>
        <description>Prescriptions for carbohydrates in parenteral nutrition solutions will be ordered individually and flipped with Numeta or &quot;vice versa&quot;. This mirroring will be performed with the Cato-Pan prescription software. Subsequently the following nutrients will be calculated and compared with each other and with the ESPGHAN recommendations</description>
        <time_frame>6 weeks</time_frame>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Fat</title>
        <description>Prescriptions for fat in parenteral nutrition solutions will be ordered individually and flipped with Numeta or &quot;vice versa&quot;. This mirroring will be performed with the Cato-Pan prescription software. Subsequently the following nutrients will be calculated and compared with each other and with the ESPGHAN recommendations</description>
        <time_frame>6 weeks</time_frame>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Sodium</title>
        <description>Prescriptions for sodium in parenteral nutrition solutions will be ordered individually and flipped with Numeta or &quot;vice versa&quot;. This mirroring will be performed with the Cato-Pan prescription software. Subsequently the following nutrients will be calculated and compared with each other and with the ESPGHAN recommendations</description>
        <time_frame>6 weeks</time_frame>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Potassium</title>
        <description>Prescriptions for Potassium in parenteral nutrition solutions will be ordered individually and flipped with Numeta or &quot;vice versa&quot;. This mirroring will be performed with the Cato-Pan prescription software. Subsequently the following nutrients will be calculated and compared with each other and with the ESPGHAN recommendations</description>
        <time_frame>6 weeks</time_frame>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Calcium</title>
        <description>Prescriptions for calcium in parenteral nutrition solutions will be ordered individually and flipped with Numeta or &quot;vice versa&quot;. This mirroring will be performed with the Cato-Pan prescription software. Subsequently the following nutrients will be calculated and compared with each other and with the ESPGHAN recommendations</description>
        <time_frame>6 weeks</time_frame>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Magnesium</title>
        <description>Prescriptions for magnesium in parenteral nutrition solutions will be ordered individually and flipped with Numeta or &quot;vice versa&quot;. This mirroring will be performed with the Cato-Pan prescription software. Subsequently the following nutrients will be calculated and compared with each other and with the ESPGHAN recommendations</description>
        <time_frame>6 weeks</time_frame>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Phosphorous</title>
        <description>Prescriptions for phosphorous in parenteral nutrition solutions will be ordered individually and flipped with Numeta or &quot;vice versa&quot;. This mirroring will be performed with the Cato-Pan prescription software. Subsequently the following nutrients will be calculated and compared with each other and with the ESPGHAN recommendations</description>
        <time_frame>6 weeks</time_frame>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Osmolarity</title>
        <description>Osmolarity in parenteral nutrition solutions will be calculated individually and flipped with Numeta or &quot;vice versa&quot;. This mirroring will be performed with the Cato-Pan prescription software. Subsequently the following nutrients will be calculated and compared with each other and with the ESPGHAN recommendations</description>
        <time_frame>6 weeks</time_frame>
      </outcome>
    </outcome_list>

    <reported_events>
      <group_list>
        <group group_id="E1">
          <title>Numeta</title>
          <description>parenteral receipt prescribed with Numeta
Numeta: parenteral receipt prescribed with Numeta
Individual: parenteral receipt prescribed individually</description>
        </group>
        <group group_id="E2">
          <title>Individual</title>
          <description>individually prescribed parenteral receipt
Numeta: parenteral receipt prescribed with Numeta
Individual: parenteral receipt prescribed individually</description>
        </group>
      </group_list>
      <serious_events>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="50"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="50"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>0</frequency_threshold>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="50"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="50"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>All Principal Investigators ARE employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed. </restrictive_agreement>
    </certain_agreements>
    <point_of_contact>
      <name_or_title>Nadja Haiden M.D.</name_or_title>
      <organization>Medical University of Vienna</organization>
      <phone>+4314040032320</phone>
      <email>nadja.haiden@meduniwien.ac.at</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

